NCT-101

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameNCT-101
Drug Alias NameNCT101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesNovacell Technology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovacell Technology Inc
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A